Internal medicine

Cancer

Oncology

Metastasis

Lymph node

Lymph node metastasis

Pancreatic cancer

Adenocarcinoma

Pancreatic ductal adenocarcinoma

Medicine

European Journal of Surgical Oncology

Overall five year survival following pancreaticoduodenectomy for ductal adenocarcinoma is poor with typical reported rates in the literature of 8–27%. The aim of this study was to identify the histological variables best able to predict long-term survival in these patients.

Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma